Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival.

Choi, Sung W

Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival. [electronic resource] - Blood Aug 2008 - 1539-42 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1528-0020

10.1182/blood-2008-02-138867 doi


Adolescent
Adult
Aged
Child
Child, Preschool
Female
Graft vs Host Disease--diagnosis
Hematopoietic Stem Cell Transplantation--adverse effects
Humans
Incidence
Infant
Infant, Newborn
Male
Middle Aged
Myeloablative Agonists--therapeutic use
Predictive Value of Tests
Prognosis
Receptors, Tumor Necrosis Factor, Type I--blood
Survival Rate
Time Factors
Transplantation Conditioning--adverse effects
Transplantation, Homologous
Tumor Necrosis Factor-alpha--analysis